A new initiative announced by the National Institutes of Health (HNIH), backed by a $1.5 billion investment from federal stimulus funding, aims to speed innovation, development, and commercialization of COVID-19 testing technologies. Dubbed the Rapid Acceleration of Diagnostics (RADx) initiative the new program will infuse funding into early innovative technologies to speed development of rapid and widely accessible COVID-19 testing.
RI Bio takes pulse of the life sciences industry
RI Bio, in collaboration with Providence Business News and RI Bio member AMGEN, has created a unique series of articles addressing key topics of concern designed to advance the life sciences. Executive Director Carol Malysz moderated a series of roundtables with Amgen...
